Drugmakers call for evidence-based approach to new drug pricing policy

The so-called positive list system reinforces the government's rash approach to shaping policies, according to a joint statement issued by the Korea Pharmaceutical Manufacturers Association (KPMA) and the Korean Research-based Pharmaceutical Industry Association on February 23.

The statement said the government should consult with clinical experts about the assessment of the existing antihyp...